✦ LIBER ✦

Predictors of timing of adjuvant chemotherapy in older women with hormone receptor–negative, stages II–III breast cancer

✍ Scribed by Stephanie B. Wheeler; William R. Carpenter; Jeffrey Peppercorn; Anna P. Schenck; Morris Weinberger; Andrea K. Biddle

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility and toxicity of dose-dense a

✍ Marjorie Zauderer; Sujata Patil; Arti Hurria 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 238 KB

Predictors of reduced dose intensity in

✍ Michelle Shayne; Jeffrey Crawford; David C. Dale; Eva Culakova; Gary H. Lyman; f 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 295 KB

Racial/ethnic differences in initiation

✍ Jennifer C. Livaudais; Dawn L. Hershman; Laurel Habel; Lawrence Kushi; Scarlett 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 201 KB

The Role of Serum CEA as a Prognostic In

✍ Richard L. Theriault; Gabriel N. Hortobagyi; Herbert A. Fritsche; Debbie Frye; R 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Adjuvant postoperative radiotherapy, che

✍ Pentti Klefström; Pentti Gröhn; Erkki Heinonen; Lars Holsti; Paul Holsti 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 614 KB

A randomized trial of CMF versus CMFVP a

✍ William C. Wood; Raymond B. Weiss; Douglass C. Tormey; James F. Holland; Patrick 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 389 KB